Cholera News and Research

Latest Cholera News and Research

The brain and fat communicate directly

Researchers examine the sensory innervation of fat cells within subcutaneous fat deposits.

4 Sep 2022

Oncolytic viruses boost the immune capacity to effectively target and destroy cancer cells

The immune system has evolved to safeguard the body from a wildly diverse range of potential threats. Among these are bacterial diseases, including plague, cholera, diphtheria and Lyme disease, and viral contagions such as influenza, Ebola virus and SARS CoV-2.

29 Aug 2022

Resistance to recognizing airborne transmission of SARS-CoV-2 may be rooted in historical error

In new research, researchers extensively searched for the origins of the resistance to recognizing airborne transmission during the coronavirus disease 2019 (COVID-19) pandemic by major public health organizations, including the World Health Organization (WHO) and the United States Centers of Disease Control and Prevention (US-CDC).

25 Aug 2022

IVI successfully completes the '2022 Introductory Course for Biologics Development and Manufacturing'

The International Vaccine Institute (IVI) successfully completed the '2022 Introductory Course for Biologics Development and Manufacturing' on July 29 to train 106 participants from 24 low- and middle-income countries (LMICs) and 32 from the Republic of Korea.

29 Jul 2022

Nasal spray highly effective against HIV and SARS-CoV-2 in animal models

The intranasal delivery of amph-protein vaccines is a potential approach to elicit a mucosal immune response against many infectious diseases.

26 Jul 2022

Researchers investigate the feasibility of modifying cholera toxin for targeted delivery to specific organelles

Proteins usually undergo modifications during or after their synthesis in the endoplasmic reticulum (ER) and Golgi apparatus network inside eukaryotic cells.

25 Jul 2022

Cholera variants need to be monitored closely to prevent outbreaks, scientists urge

Cholera variants are constantly evolving and need to be monitored closely to prevent outbreaks, say researchers.

20 Jul 2022

Gut-lung axis: Using commensal bacteria to reinforce mucosal immunity

A recent study discusses the use of commensal bacteria in the gut and/or respiratory tract to deliver viral antigens to the host, thus acting as vaccines

19 Jul 2022

DNA may act as nutritional source for E. coli

Findings of a new experiment could be helpful in understanding how DNA acts as a nutrient for gut bacteria, and its impact on the health of the host.

18 Jul 2022

New study discloses the reason behind the disappearance of highly infectious cholera variant

A new study reveals why a highly infectious variant of the cholera bug, which caused large disease outbreaks in the early 1990s, did not cause the eighth cholera pandemic as feared – but instead unexpectedly disappeared.

5 Jul 2022

Researchers discover new family of sensing genes in enteric bacteria using AI

Using artificial intelligence, UT Southwestern researchers have discovered a new family of sensing genes in enteric bacteria that are linked by structure and probably function, but not genetic sequence.

30 Jun 2022

Review addresses the need for innovative adjuvant approaches and delivery strategies for the advancement of new mucosal vaccines

Researchers reviewed available mucosal vaccines discussing the current challenges and ways to advance the existing approaches.

25 May 2022

IVI and partners to provide two doses of oral vaccine to 100,000 people at risk of cholera in Ethiopia

The International Vaccine Institute, in collaboration with LG Electronics, the Ethiopian government led by Armauer Hansen Research Institute, and the Ethiopian Public Health Institute, will vaccinate 40,000 people against cholera in May to support prevention of the disease in Ethiopia.

13 May 2022

SK bioscience's typhoid vaccine licensed for export by Korean Ministry of Food and Drug Safety

The International Vaccine Institute (IVI) and SK bioscience announced today that SK bioscience obtained an export license from the Korean Ministry of Food and Drug Safety for SK's typhoid vaccine 'SKYTyphoid' which they jointly developed.

12 May 2022

World Immunization Week 2022: Gavi, The Vaccine Alliance on the equitable and sustainable use of vaccines

As part of World Immunization Week 2022, News Medical speaks to Thabani Maphosa, the Managing Director of Country Programmes at Gavi, The Vaccine Alliance, about their work to increase equitable and sustainable use of vaccines by maximizing financial investments, bringing the best partners to the table and driving innovation.

27 Apr 2022

Cholera News and Research

Latest Cholera News and Research

The brain and fat communicate directly

Oncolytic viruses boost the immune capacity to effectively target and destroy cancer cells

Resistance to recognizing airborne transmission of SARS-CoV-2 may be rooted in historical error

IVI successfully completes the '2022 Introductory Course for Biologics Development and Manufacturing'

Nasal spray highly effective against HIV and SARS-CoV-2 in animal models

Researchers investigate the feasibility of modifying cholera toxin for targeted delivery to specific organelles

Cholera variants need to be monitored closely to prevent outbreaks, scientists urge

Gut-lung axis: Using commensal bacteria to reinforce mucosal immunity

DNA may act as nutritional source for E. coli

New study discloses the reason behind the disappearance of highly infectious cholera variant

Researchers discover new family of sensing genes in enteric bacteria using AI

Review addresses the need for innovative adjuvant approaches and delivery strategies for the advancement of new mucosal vaccines

IVI and partners to provide two doses of oral vaccine to 100,000 people at risk of cholera in Ethiopia

SK bioscience's typhoid vaccine licensed for export by Korean Ministry of Food and Drug Safety

World Immunization Week 2022: Gavi, The Vaccine Alliance on the equitable and sustainable use of vaccines

World Immunization Week 2022: Striving for a Long Life for All with the International Vaccine Institute

Impact of COVID-19 pandemic on vaccination campaigns for diseases preventable by vaccine

World Health Day; Creating a Better Planet for a #HealthierTomorrow

Illinois Tech receives $2.17 million NIH grant to develop drug treatments for cholera

Study provides new insights into the communication of bacteria with their host

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Cholera News and Research

Latest Cholera News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in